Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Wait Pausing Investments

Polpharma SA is a Polish pharmaceutical company that produces medicines for cardiology, gastroenterology and neurology.

Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Wait Pausing Investments
The Company Statement
March 28, 2022

March 28: Suspended all new investments in Russia. Shipments to Russia only include essential drugs. Prior to March 28, sold pediatric products and products used for treatment of acute or chornic medical conditions. Donating medications to Ukraine. Does not import any medicines, active ingredients, or raw materials for production from Russia or Belarus. (Akrikhin, a Russian pharmaceutical company, is listed as an asset. Poland's largest drug maker)

All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.